ATLAS VENTURE ADVISORS, INC. Holdings

ATLAS VENTURE ADVISORS, INC. is an investment fund managing more than 277.61M US dollars. The largest holdings include Integral Ad Science Holding Corp., DraftKings and Viridian Therapeutics. In Q2 2022 the fund bought assets of total value of 76.5M US dollars and sold assets of total value of 127.64M US dollars.

$277.60M

portfolio value

-12.34%

quarter

-65.00%

1 year

-528.05%

3 years

ATLAS VENTURE ADVISORS, INC. portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q2 2020	279281000	849000
Q4 2020	9121000	171181000
Q2 2021	467634000	8959000
Q4 2021	35900000	12797000
Q2 2022	76504000	127638000

ATLAS VENTURE ADVISORS, INC. 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Advertising Agencies Integral Ad Science Holding Corp. Portfolio share: 59.26% Portfolio value: 164.51M Avg. open price: $20.63 Current price: $9.63 P/L: -53.32% Bought 0.00% shares Q4 2021	share	59.26%	164.51M	$20.63	$9.63	-53.32%	Bought 0.00% shares Q4 2021
Gambling DraftKings Inc. Portfolio share: 35.75% Portfolio value: 99.25M Avg. open price: N/A Current price: $14.83 P/L: N/A N/A Q2 2022	share	35.75%	99.25M	N/A	$14.83	N/A	N/A Q2 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 1.55% Portfolio value: 4.29M Avg. open price: N/A Current price: $26.84 P/L: N/A N/A Q4 2020	share	1.55%	4.29M	N/A	$26.84	N/A	N/A Q4 2020
Entertainment Roku, Inc. Portfolio share: 1.17% Portfolio value: 3.25M Avg. open price: N/A Current price: $56.42 P/L: N/A N/A Q4 2019	share	1.17%	3.25M	N/A	$56.42	N/A	N/A Q4 2019
Biotechnology F-star Therapeutics, Inc. Portfolio share: 1.06% Portfolio value: 2.94M Avg. open price: N/A Current price: $5.55 P/L: N/A N/A Q4 2020	share	1.06%	2.94M	N/A	$5.55	N/A	N/A Q4 2020
Internet Content & Information Snap Inc. Portfolio share: 0.87% Portfolio value: 2.41M Avg. open price: $14.3 Current price: $10.1 P/L: -29.37% Bought +0.20% shares Q3 2019	share	0.87%	2.41M	$14.3	$10.1	-29.37%	Bought +0.20% shares Q3 2019
Biotechnology Larimar Therapeutics, Inc. Portfolio share: 0.34% Portfolio value: 935K Avg. open price: N/A Current price: $3.15 P/L: N/A N/A Q2 2020	share	0.34%	935K	N/A	$3.15	N/A	N/A Q2 2020

Showing TOP 7 ATLAS VENTURE ADVISORS's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ATLAS VENTURE ADVISORS, INC.?

The biggest position of the ATLAS VENTURE ADVISORS, INC. is Integral Ad Science Holding Corp. (IAS) with 59.26% portfolio share worth of 164.51M US dollars.

Top 5 ATLAS VENTURE ADVISORS's holdings represent 98.79% of the portfolio:

Integral Ad Science Holding Corp. (IAS) – 59.26%
DraftKings Inc. (DKNG) – 35.75%
Viridian Therapeutics, Inc. (VRDN) – 1.55%
Roku, Inc. (ROKU) – 1.17%
F-star Therapeutics, Inc. (FSTX) – 1.06%

Who is the portfolio manager of ATLAS VENTURE ADVISORS, INC.?

The portfolio manager of the ATLAS VENTURE ADVISORS, INC. is .

What is the total asset value of the ATLAS VENTURE ADVISORS, INC. portfolio?

ATLAS VENTURE ADVISORS, INC. total asset value (portfolio value) is 277.61M US dollars.

Who is ?

is the portfolio manager of the ATLAS VENTURE ADVISORS, INC..

What is (ATLAS VENTURE ADVISORS, INC.) fund performance?

ATLAS VENTURE ADVISORS's quarterly performance is -12.34%, annualy -65.00%. In the past 3 years, the value of 's portfolio has decreased by -528%.

What is the ATLAS VENTURE ADVISORS, INC. CIK?

ATLAS VENTURE ADVISORS's Central Index Key is 0001767432 .